Compositions and methods for treatment of neovascular diseases

Details for Australian Patent Application No. 2005249586 (hide)

Owner The Scripps Research Institute

Inventors Aguilar, Hilda Edith; Dorrell, Michael I.; Friedlander, Martin

Agent Griffith Hack

Pub. Number AU-B-2005249586

PCT Pub. Number WO2005/117954

Priority 60/655,801 24.02.05 US; 60/577,156 04.06.04 US; 60/585,273 01.07.04 US

Filing date 6 June 2005

Wipo publication date 15 December 2005

Acceptance publication date 23 December 2010

International Classifications

C07K 1/00 (2006.01) General processes for the preparation of peptides

A01N 43/04 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/538 (2006.01)

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/7072 (2006.01)

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 38/47 (2006.01) Medicinal preparations containing peptides

A61K 38/51 (2006.01) Medicinal preparations containing peptides

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 17/00 (2006.01) Carrier-bound or immobilised peptides

C12N 9/00 (2006.01) Enzymes, e.g. ligases (6.)

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/117954 Priority application(s): WO2005/117954

23 December 2010 Application Accepted

  Published as AU-B-2005249586

21 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249593-Methods of treating cellular proliferative disease using naphthalimide and PARP-1 inhibitors

2005249581-Pharmaceutical compositions for the treatment of pruritus